Conclusion: PTEN upregulation and the concurrent NIS and PTEN nuclear translocation in Res-suppressed ATC cells may indicate the better therapeutic outcome and would be a group of beneficial prognostic factors of ATCs. The gene discussed is PTEN; the disease is Ehlers-Danlos syndrome, musculocontractural type.